A vulnerability in Cisco WebEx Meeting Center could allow an authenticated, remote attacker to initiate connections to arbitrary hosts. The vulnerability is due to insufficient access control for HTTP traffic directed to the Cisco WebEx Meeting Center. An attacker could exploit this vulnerability by sending a malicious URL to the Cisco WebEx Meeting Center. An exploit could allow the attacker to connect to arbitrary hosts. There are no workarounds that address this vulnerability. This advisory is available at the following link: https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-20171129-wmc
For the latest and most detailed information about fixed software releases, consult the Cisco bug ID(s) at the top of this advisory.
The Cisco Product Security Incident Response Team (PSIRT) is not aware of any public announcements or malicious use of the vulnerability that is described in this advisory.
Cisco would like to thank Hanson Nottingham, Security Researcher at Blue Shield of California for reporting this vulnerability.
To learn about Cisco security vulnerability disclosure policies and publications, see the Security Vulnerability Policy. This document also contains instructions for obtaining fixed software and receiving security vulnerability information from Cisco.
| Version | Description | Section | Status | Date |
|---|---|---|---|---|
| 1.0 | Initial public release. | - | Final | 2017-November-29 |
THIS DOCUMENT IS PROVIDED ON AN "AS IS" BASIS AND DOES NOT IMPLY ANY KIND OF GUARANTEE OR WARRANTY, INCLUDING THE WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE. YOUR USE OF THE INFORMATION ON THE DOCUMENT OR MATERIALS LINKED FROM THE DOCUMENT IS AT YOUR OWN RISK. CISCO RESERVES THE RIGHT TO CHANGE OR UPDATE THIS DOCUMENT AT ANY TIME.
A standalone copy or paraphrase of the text of this document that omits the distribution URL is an uncontrolled copy and may lack important information or contain factual errors. The information in this document is intended for end users of Cisco products.
Vulmon